Consistent with the analysis in our tumor samples, SLX4IP deficiencies in our cell lines are mutually exclusive with ATRX, DAXX, SMARCAL1, and H3.3, raising the possibility that SLX4IP may represent another gene deficiency associated with ALT activity. This evidence concerns the gene ATRX and neoplasm.